IMV Medical Information’s Post

Yesterday Joga Gobburu joined the star-studded panel at the FDA's An Introduction to the CDER Quantitative Medicine Center of Excellence Workshop. Among the points made around I-C-E (Innovation - Collaboration - Empowerment), the discussion around how COE QM can spark regulatory innovation might be most relevant to regulatory intelligence and policy specialists. There are two specific topics that will affect regulatory professionals: COE QM could help with acceptance of novel quantitative approaches across FDA decreasing the regulatory uncertainty; and this Center has the opportunity to expand Model-Integrated Evidence to unprecedented scenarios. Let us chat about how MIDD can give a competitive edge (sales@vivpro.ai) ! https://lnkd.in/g4YWZEDg

🔔WCG Featured🔔 Our very own Amy Thue and Shelby Ward share their insights in Pharma Focus America!  Read their article focused on prioritizing the participation experience in #clinicaltrials to ensure a successful future of clinical research. Access now at https://lnkd.in/e-hy8QkD #clinicalresearch #retention #WCG 

From modernising clinical research to optimising regulatory relationships......empowering patient-centric research to efficient recruitment and retention......what is being discussed at EUCROF25...... EUCROF is delighted to announce that the programme for EUCROF25, the 2025 European Clinical Research Conference, is now available. EUCROF25 offers attendees an extensive array of presentations, expert panel discussions, interactive workshops, and breakout sessions, which will reflect the current state of clinical research while also exploring the pressing challenges and exciting opportunities that lie ahead. View the programme here: https://lnkd.in/eEYsx8WT Dr. Martine Dehlinger-Kremer, Simon Lee, Martin O'Kane, Sverre Bengtsson, Benedikt Van Nieuwenhove, Alexandre Malouvier, Antonio Torres, Nicole Bohrmann, Cristina Florescu Moraid, Alan Yeomans, Nira Garty #EUCROF #clinicalresearch #clinicaltrials #clinicaloperations #gcp #bigpharma #dct #EUCROF25

Türkiye is becoming an attractive destination for clinical trials due to its robust healthcare infrastructure and a large pool of treatment-naive patients. In our latest video interview, CEO of Cromos Pharma, Vlad Bogin, MD, FACP, speaks with Seniz Sagol Tuysuz, the Country Head of Cromos Pharma in Türkiye. They explore why Türkiye is emerging as a biotech hub, discussing the clinical trial landscape, regulatory environment, quality and safety measures, patient recruitment, and best practices for successful trials. Discover why Türkiye should be considered for the next clinical research venture: https://lnkd.in/edcWNWyk #Podcast #Türkiye #CromosPharma 

Türkiye is becoming an attractive destination for clinical trials due to its robust healthcare infrastructure and a large pool of treatment-naive patients. In our latest video interview, CEO of Cromos Pharma, Vlad Bogin, MD, FACP, speaks with Seniz Sagol Tuysuz, the Country Head of Cromos Pharma in Türkiye. They explore why Türkiye is emerging as a biotech hub, discussing the clinical trial landscape, regulatory environment, quality and safety measures, patient recruitment, and best practices for successful trials. Discover why Türkiye should be considered for the next clinical research venture: https://lnkd.in/edcWNWyk #Podcast #Türkiye #CromosPharma

Check out this insightful interview with Vlad Bogin, MD, FACP and Seniz Sagol Tuysuz, Country Head in Türkiye, discussing why Türkiye is a top destination for clinical trials! 🌍🔬 Watch here: https://lnkd.in/e6yGt9UN

Türkiye is becoming an attractive destination for clinical trials due to its robust healthcare infrastructure and a large pool of treatment-naive patients. In our latest video interview, CEO of Cromos Pharma, Vlad Bogin, MD, FACP, speaks with Seniz Sagol Tuysuz, the Country Head of Cromos Pharma in Türkiye. They explore why Türkiye is emerging as a biotech hub, discussing the clinical trial landscape, regulatory environment, quality and safety measures, patient recruitment, and best practices for successful trials. Discover why Türkiye should be considered for the next clinical research venture: https://lnkd.in/e6EgU7Gb #Podcast #Türkiye #CromosPharma

🌐 Join EmVenio Research for an upcoming webinar on the vital role of efficient study start-up processes in clinical research! The featured speakers will share strategies to streamline the start-up phase—from protocol feasibility to regulatory submissions and site activation. Gain practical insights into overcoming challenges, reducing time-to-initiation, and fostering smooth collaboration between sponsors, CROs, and sites. ➡️ Learn more + register here: https://buff.ly/3ZCRhJA 🌟 Featured speakers: Jack Evans Tara Kidwell #ClinicalTrials #DrugDevelopment #ClinicalResearch #ClinicalOperations #ClinicalData #SiteManagement #ClinicalSites #DecentralizedClinicalTrials #SiteNetwork

Türkiye is becoming an attractive destination for clinical trials due to its robust healthcare infrastructure and a large pool of treatment-naive patients.    In our latest video interview, CEO of Cromos Pharma, @Vlad Bogin, MD, FACP Bogin, speaks with @Seniz Sagol, the Country Head of Cromos Pharma in Türkiye. They explore why Türkiye is emerging as a biotech hub, discussing the clinical trial landscape, regulatory environment, quality and safety measures, patient recruitment, and best practices for successful trials.    Discover why Türkiye should be considered for the next clinical research venture:  https://lnkd.in/eHF4Q3jf   #Podcast #Türkiye #CromosPharma #clinicaltrials #clinicalresearch

Programme EUCROF25 is available. The most significant topics about the current state of clinical research. See you on EUCROF25.